APO Research
Talk to an analyst

APO RESEARCH · REPORT

Immunology Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Immunology Drug Market Outlook and Growth Opportunities 2026

20 December 2025194 pages

Choose your research edition.

Industry ResearchImmunology Drug Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Immunology Drug Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Immunology Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immunology Drug Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Immunology Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Immunology Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Immunology Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Immunology Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Immunology Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Immunology Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Immunology Drug market include Eisai Co., Eli Lilly and Company, Pfizer, GlaxoSmithKline plc, Bayer AG, Seattle Genetics, Sanofi Aventis LLC., Genentech and F. Hoffmann-La Roche Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Immunology Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Immunology Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Immunology Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Immunology Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Immunology Drug Segment by Company

Eisai Co.

Eli Lilly and Company

Pfizer

GlaxoSmithKline plc

Bayer AG

Seattle Genetics

Sanofi Aventis LLC.

Genentech

F. Hoffmann-La Roche Ltd.

Autoimmune Inc.

Active Biotech

Abbott Laboratories

Immunology Drug Segment by Type

Monoclonal Antibodies (mAb)

Antibody Drug Conjugates

Immunosuppressive medication

Others

Immunology Drug Segment by Application

Cancer Research Centers and Institutes

Hospitals

Clinics

Immunology Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Immunology Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Immunology Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Immunology Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Immunology Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunology Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immunology Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunology Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Immunology Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Immunology Drug industry.

Chapter 3: Detailed analysis of Immunology Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Immunology Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Immunology Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Immunology Drug Industry Trends Table 2. Immunology Drug Industry Drivers Table 3. Immunology Drug Industry Opportunities and Challenges Table 4. Immunology Drug Industry Restraints Table 5. Global Immunology Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Immunology Drug Revenue Share by Company (2021-2026) Table 7. Global Immunology Drug Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Immunology Drug Sales Volume Share by Company (2021-2026) Table 9. Global Immunology Drug Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Immunology Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Immunology Drug Key Company Manufacturing Base & Headquarters Table 12. Global Immunology Drug Company, Product Type & Application Table 13. Global Immunology Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Immunology Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Monoclonal Antibodies (mAb) Table 18. Significant Companies of Antibody Drug Conjugates Table 19. Significant Companies of Immunosuppressive medication Table 20. Significant Companies of Others Table 21. Global Immunology Drug Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Immunology Drug Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Immunology Drug Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Immunology Drug Sales Volume Share by Type (2021-2026) Table 25. Global Immunology Drug Sales Volume Share by Type (2027-2032) Table 26. Global Immunology Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Immunology Drug Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Immunology Drug Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Immunology Drug Sales Value Share by Type (2021-2026) Table 30. Global Immunology Drug Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Cancer Research Centers and Institutes Table 32. Significant Companies of Hospitals Table 33. Significant Companies of Clinics Table 34. Global Immunology Drug Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Immunology Drug Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Immunology Drug Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Immunology Drug Sales Volume Share by Application (2021-2026) Table 38. Global Immunology Drug Sales Volume Share by Application (2027-2032) Table 39. Global Immunology Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Immunology Drug Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Immunology Drug Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Immunology Drug Sales Value Share by Application (2021-2026) Table 43. Global Immunology Drug Sales Value Share by Application (2027-2032) Table 44. Global Immunology Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Immunology Drug Sales by Region (2021-2026) & (K Units) Table 46. Global Immunology Drug Sales Market Share by Region (2021-2026) Table 47. Global Immunology Drug Sales by Region (2027-2032) & (K Units) Table 48. Global Immunology Drug Sales Market Share by Region (2027-2032) Table 49. Global Immunology Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Immunology Drug Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Immunology Drug Sales Value Share by Region (2021-2026) Table 52. Global Immunology Drug Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Immunology Drug Sales Value Share by Region (2027-2032) Table 54. Global Immunology Drug Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Immunology Drug Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Immunology Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Immunology Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Immunology Drug Sales by Country (2021-2026) & (K Units) Table 59. Global Immunology Drug Sales Market Share by Country (2021-2026) Table 60. Global Immunology Drug Sales by Country (2027-2032) & (K Units) Table 61. Global Immunology Drug Sales Market Share by Country (2027-2032) Table 62. Global Immunology Drug Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Immunology Drug Sales Value Market Share by Country (2021-2026) Table 64. Global Immunology Drug Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Immunology Drug Sales Value Market Share by Country (2027-2032) Table 66. Eisai Co. Company Information Table 67. Eisai Co. Business Overview Table 68. Eisai Co. Immunology Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Eisai Co. Immunology Drug Product Portfolio Table 70. Eisai Co. Recent Development Table 71. Eli Lilly and Company Company Information Table 72. Eli Lilly and Company Business Overview Table 73. Eli Lilly and Company Immunology Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Eli Lilly and Company Immunology Drug Product Portfolio Table 75. Eli Lilly and Company Recent Development Table 76. Pfizer Company Information Table 77. Pfizer Business Overview Table 78. Pfizer Immunology Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Pfizer Immunology Drug Product Portfolio Table 80. Pfizer Recent Development Table 81. GlaxoSmithKline plc Company Information Table 82. GlaxoSmithKline plc Business Overview Table 83. GlaxoSmithKline plc Immunology Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. GlaxoSmithKline plc Immunology Drug Product Portfolio Table 85. GlaxoSmithKline plc Recent Development Table 86. Bayer AG Company Information Table 87. Bayer AG Business Overview Table 88. Bayer AG Immunology Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Bayer AG Immunology Drug Product Portfolio Table 90. Bayer AG Recent Development Table 91. Seattle Genetics Company Information Table 92. Seattle Genetics Business Overview Table 93. Seattle Genetics Immunology Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Seattle Genetics Immunology Drug Product Portfolio Table 95. Seattle Genetics Recent Development Table 96. Sanofi Aventis LLC. Company Information Table 97. Sanofi Aventis LLC. Business Overview Table 98. Sanofi Aventis LLC. Immunology Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Sanofi Aventis LLC. Immunology Drug Product Portfolio Table 100. Sanofi Aventis LLC. Recent Development Table 101. Genentech Company Information Table 102. Genentech Business Overview Table 103. Genentech Immunology Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Genentech Immunology Drug Product Portfolio Table 105. Genentech Recent Development Table 106. F. Hoffmann-La Roche Ltd. Company Information Table 107. F. Hoffmann-La Roche Ltd. Business Overview Table 108. F. Hoffmann-La Roche Ltd. Immunology Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. F. Hoffmann-La Roche Ltd. Immunology Drug Product Portfolio Table 110. F. Hoffmann-La Roche Ltd. Recent Development Table 111. Autoimmune Inc. Company Information Table 112. Autoimmune Inc. Business Overview Table 113. Autoimmune Inc. Immunology Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Autoimmune Inc. Immunology Drug Product Portfolio Table 115. Autoimmune Inc. Recent Development Table 116. Active Biotech Company Information Table 117. Active Biotech Business Overview Table 118. Active Biotech Immunology Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Active Biotech Immunology Drug Product Portfolio Table 120. Active Biotech Recent Development Table 121. Abbott Laboratories Company Information Table 122. Abbott Laboratories Business Overview Table 123. Abbott Laboratories Immunology Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Abbott Laboratories Immunology Drug Product Portfolio Table 125. Abbott Laboratories Recent Development Table 126. Key Raw Materials Table 127. Raw Materials Key Suppliers Table 128. Immunology Drug Distributors List Table 129. Immunology Drug Customers List Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Immunology Drug Product Image Figure 2. Global Immunology Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immunology Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Immunology Drug Sales (2021-2032) & (K Units) Figure 5. Global Immunology Drug Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Immunology Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Monoclonal Antibodies (mAb) Image Figure 10. Antibody Drug Conjugates Image Figure 11. Immunosuppressive medication Image Figure 12. Others Image Figure 13. Global Immunology Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Immunology Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Immunology Drug Sales Volume Share by Type (2021-2032) Figure 16. Global Immunology Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Immunology Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Immunology Drug Sales Value Share by Type (2021-2032) Figure 19. Cancer Research Centers and Institutes Image Figure 20. Hospitals Image Figure 21. Clinics Image Figure 22. Global Immunology Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Immunology Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Immunology Drug Sales Volume Share by Application (2021-2032) Figure 25. Global Immunology Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Immunology Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Immunology Drug Sales Value Share by Application (2021-2032) Figure 28. Global Immunology Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Immunology Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Immunology Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Immunology Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Immunology Drug Sales Value (2021-2032) & (US$ Million) Figure 33. North America Immunology Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Immunology Drug Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Immunology Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Immunology Drug Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Immunology Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Immunology Drug Sales Value (2021-2032) & (US$ Million) Figure 39. South America Immunology Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Immunology Drug Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Immunology Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Immunology Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Immunology Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Immunology Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Immunology Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Immunology Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Immunology Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Immunology Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Immunology Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Immunology Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Immunology Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Immunology Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Immunology Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Immunology Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Immunology Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Immunology Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Immunology Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Immunology Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Immunology Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Immunology Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Immunology Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Immunology Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Immunology Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Immunology Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Immunology Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Immunology Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Immunology Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Immunology Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Immunology Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Immunology Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Immunology Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Immunology Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Immunology Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Immunology Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Immunology Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Immunology Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Immunology Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Immunology Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Immunology Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Immunology Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Immunology Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Immunology Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Immunology Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Immunology Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Immunology Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Immunology Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Immunology Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Immunology Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Immunology Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Immunology Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Immunology Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Immunology Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Immunology Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Immunology Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Immunology Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Immunology Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Immunology Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Immunology Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Immunology Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Immunology Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Immunology Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Immunology Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Immunology Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Immunology Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Immunology Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Immunology Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Immunology Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Immunology Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Immunology Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Immunology Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Immunology Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Immunology Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Immunology Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Immunology Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Immunology Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Immunology Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Immunology Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Immunology Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Immunology Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Immunology Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Immunology Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Immunology Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Immunology Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Immunology Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Immunology Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Immunology Drug Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Immunology Drug Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Monoclonal Antibodies (mAb)
  • Antibody Drug Conjugates
  • Immunosuppressive medication
  • Others
Applications
  • Cancer Research Centers and Institutes
  • Hospitals
  • Clinics
Companies covered
  • Eisai Co.
  • Eli Lilly and Company
  • Pfizer
  • GlaxoSmithKline plc
  • Bayer AG
  • Seattle Genetics
  • Sanofi Aventis LLC.
  • Genentech
  • F. Hoffmann-La Roche Ltd.
  • Autoimmune Inc.
  • Active Biotech
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Immunology Drug Sales Value (2021-2032)
  4. 1.2.2 Global Immunology Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Immunology Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Immunology Drug Market Dynamics
  1. 2.1 Immunology Drug Industry Trends
  2. 2.2 Immunology Drug Industry Drivers
  3. 2.3 Immunology Drug Industry Opportunities and Challenges
  4. 2.4 Immunology Drug Industry Restraints
3 Immunology Drug Market by Company
  1. 3.1 Global Immunology Drug Company Revenue Ranking in 2025
  2. 3.2 Global Immunology Drug Revenue by Company (2021-2026)
  3. 3.3 Global Immunology Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Immunology Drug Average Price by Company (2021-2026)
  5. 3.5 Global Immunology Drug Company Ranking (2024-2026)
  6. 3.6 Global Immunology Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Immunology Drug Company Product Type and Application
  8. 3.8 Global Immunology Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Immunology Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Immunology Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Immunology Drug Market by Type
  1. 4.1 Immunology Drug Type Introduction
  2. 4.1.1 Monoclonal Antibodies (mAb)
  3. 4.1.2 Antibody Drug Conjugates
  4. 4.1.3 Immunosuppressive medication
  5. 4.1.4 Others
  6. 4.2 Global Immunology Drug Sales Volume by Type
  7. 4.2.1 Global Immunology Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Immunology Drug Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Immunology Drug Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Immunology Drug Sales Value by Type
  11. 4.3.1 Global Immunology Drug Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Immunology Drug Sales Value by Type (2021-2032)
  13. 4.3.3 Global Immunology Drug Sales Value Share by Type (2021-2032)
5 Immunology Drug Market by Application
  1. 5.1 Immunology Drug Application Introduction
  2. 5.1.1 Cancer Research Centers and Institutes
  3. 5.1.2 Hospitals
  4. 5.1.3 Clinics
  5. 5.2 Global Immunology Drug Sales Volume by Application
  6. 5.2.1 Global Immunology Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Immunology Drug Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Immunology Drug Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Immunology Drug Sales Value by Application
  10. 5.3.1 Global Immunology Drug Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Immunology Drug Sales Value by Application (2021-2032)
  12. 5.3.3 Global Immunology Drug Sales Value Share by Application (2021-2032)
6 Immunology Drug Regional Sales and Value Analysis
  1. 6.1 Global Immunology Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Immunology Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Immunology Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Immunology Drug Sales by Region (2027-2032)
  5. 6.3 Global Immunology Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Immunology Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Immunology Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Immunology Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Immunology Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Immunology Drug Sales Value (2021-2032)
  12. 6.6.2 North America Immunology Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Immunology Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Immunology Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Immunology Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Immunology Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Immunology Drug Sales Value (2021-2032)
  21. 6.9.2 South America Immunology Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Immunology Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Immunology Drug Sales Value Share by Country, 2025 VS 2032
7 Immunology Drug Country-level Sales and Value Analysis
  1. 7.1 Global Immunology Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Immunology Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Immunology Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Immunology Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Immunology Drug Sales by Country (2027-2032)
  6. 7.4 Global Immunology Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Immunology Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Immunology Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Immunology Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Immunology Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Immunology Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Immunology Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Immunology Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Immunology Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Immunology Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Immunology Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Immunology Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Immunology Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Immunology Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Immunology Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Immunology Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Immunology Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Immunology Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Immunology Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Immunology Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Immunology Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Immunology Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Immunology Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Immunology Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Immunology Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Immunology Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Immunology Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Immunology Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Immunology Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Immunology Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Immunology Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Immunology Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Immunology Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Immunology Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Immunology Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Immunology Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Immunology Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Immunology Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Immunology Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Immunology Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Immunology Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Immunology Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Immunology Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Immunology Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Immunology Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Immunology Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Immunology Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Immunology Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Immunology Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Immunology Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Immunology Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Immunology Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Immunology Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Immunology Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Immunology Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Immunology Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Immunology Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Immunology Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Immunology Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Immunology Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Immunology Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Immunology Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Immunology Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Immunology Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Immunology Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Immunology Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Immunology Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Immunology Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Immunology Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Immunology Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Immunology Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Immunology Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Immunology Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Immunology Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Immunology Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Immunology Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Immunology Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Immunology Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Immunology Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Immunology Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Immunology Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Immunology Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Immunology Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Immunology Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Immunology Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Immunology Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Immunology Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eisai Co.
  2. 8.1.1 Eisai Co. Company Information
  3. 8.1.2 Eisai Co. Business Overview
  4. 8.1.3 Eisai Co. Immunology Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Eisai Co. Immunology Drug Product Portfolio
  6. 8.1.5 Eisai Co. Recent Developments
  7. 8.2 Eli Lilly and Company
  8. 8.2.1 Eli Lilly and Company Company Information
  9. 8.2.2 Eli Lilly and Company Business Overview
  10. 8.2.3 Eli Lilly and Company Immunology Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Eli Lilly and Company Immunology Drug Product Portfolio
  12. 8.2.5 Eli Lilly and Company Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Immunology Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Immunology Drug Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 GlaxoSmithKline plc
  20. 8.4.1 GlaxoSmithKline plc Company Information
  21. 8.4.2 GlaxoSmithKline plc Business Overview
  22. 8.4.3 GlaxoSmithKline plc Immunology Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 GlaxoSmithKline plc Immunology Drug Product Portfolio
  24. 8.4.5 GlaxoSmithKline plc Recent Developments
  25. 8.5 Bayer AG
  26. 8.5.1 Bayer AG Company Information
  27. 8.5.2 Bayer AG Business Overview
  28. 8.5.3 Bayer AG Immunology Drug Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Bayer AG Immunology Drug Product Portfolio
  30. 8.5.5 Bayer AG Recent Developments
  31. 8.6 Seattle Genetics
  32. 8.6.1 Seattle Genetics Company Information
  33. 8.6.2 Seattle Genetics Business Overview
  34. 8.6.3 Seattle Genetics Immunology Drug Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Seattle Genetics Immunology Drug Product Portfolio
  36. 8.6.5 Seattle Genetics Recent Developments
  37. 8.7 Sanofi Aventis LLC.
  38. 8.7.1 Sanofi Aventis LLC. Company Information
  39. 8.7.2 Sanofi Aventis LLC. Business Overview
  40. 8.7.3 Sanofi Aventis LLC. Immunology Drug Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sanofi Aventis LLC. Immunology Drug Product Portfolio
  42. 8.7.5 Sanofi Aventis LLC. Recent Developments
  43. 8.8 Genentech
  44. 8.8.1 Genentech Company Information
  45. 8.8.2 Genentech Business Overview
  46. 8.8.3 Genentech Immunology Drug Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Genentech Immunology Drug Product Portfolio
  48. 8.8.5 Genentech Recent Developments
  49. 8.9 F. Hoffmann-La Roche Ltd.
  50. 8.9.1 F. Hoffmann-La Roche Ltd. Company Information
  51. 8.9.2 F. Hoffmann-La Roche Ltd. Business Overview
  52. 8.9.3 F. Hoffmann-La Roche Ltd. Immunology Drug Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 F. Hoffmann-La Roche Ltd. Immunology Drug Product Portfolio
  54. 8.9.5 F. Hoffmann-La Roche Ltd. Recent Developments
  55. 8.10 Autoimmune Inc.
  56. 8.10.1 Autoimmune Inc. Company Information
  57. 8.10.2 Autoimmune Inc. Business Overview
  58. 8.10.3 Autoimmune Inc. Immunology Drug Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Autoimmune Inc. Immunology Drug Product Portfolio
  60. 8.10.5 Autoimmune Inc. Recent Developments
  61. 8.11 Active Biotech
  62. 8.11.1 Active Biotech Company Information
  63. 8.11.2 Active Biotech Business Overview
  64. 8.11.3 Active Biotech Immunology Drug Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Active Biotech Immunology Drug Product Portfolio
  66. 8.11.5 Active Biotech Recent Developments
  67. 8.12 Abbott Laboratories
  68. 8.12.1 Abbott Laboratories Company Information
  69. 8.12.2 Abbott Laboratories Business Overview
  70. 8.12.3 Abbott Laboratories Immunology Drug Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Abbott Laboratories Immunology Drug Product Portfolio
  72. 8.12.5 Abbott Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Immunology Drug Value Chain Analysis
  2. 9.1.1 Immunology Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Immunology Drug Sales Mode & Process
  6. 9.2 Immunology Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Immunology Drug Distributors
  9. 9.2.3 Immunology Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst